MedKoo Cat#: 591384 | Name: AGN 191701

Description:

WARNING: This product is for research use only, not for human or veterinary use.

AGN 191701 is a Retinoid X receptor agonist.

Chemical Structure

AGN 191701
AGN 191701
CAS#156691-84-8

Theoretical Analysis

MedKoo Cat#: 591384

Name: AGN 191701

CAS#: 156691-84-8

Chemical Formula: C23H28O2S

Exact Mass: 368.1810

Molecular Weight: 368.54

Elemental Analysis: C, 74.96; H, 7.66; O, 8.68; S, 8.70

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
AGN 191701; AGN-191701; AGN191701
IUPAC/Chemical Name
3-Thiophenecarboxylic acid, 5-(2-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-1-propenyl)-, (E)-
InChi Key
ZEDKEKWGCXBKCJ-NTEUORMPSA-N
InChi Code
InChI=1S/C23H28O2S/c1-14(9-17-11-16(13-26-17)21(24)25)18-12-20-19(10-15(18)2)22(3,4)7-8-23(20,5)6/h9-13H,7-8H2,1-6H3,(H,24,25)/b14-9+
SMILES Code
O=C(C1=CSC(/C=C(C2=C(C)C=C3C(C)(C)CCC(C)(C)C3=C2)\C)=C1)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 368.54 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Standeven AM, Thacher SM, Yuan YD, Escobar M, Vuligonda V, Beard RL, Chandraratna RA. Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents. Biochem Pharmacol. 2001 Dec 1;62(11):1501-9. PubMed PMID: 11728386. 2: Elmazar MM, Rühl R, Nau H. Synergistic teratogenic effects induced by retinoids in mice by coadministration of a RARalpha- or RARgamma-selective agonist with a RXR-selective agonist. Toxicol Appl Pharmacol. 2001 Jan 1;170(1):2-9. PubMed PMID: 11141350. 3: Pakala R, Benedict CR. Modulation of endothelial cell proliferation by retinoid x receptor agonists. Eur J Pharmacol. 1999 Dec 3;385(2-3):255-61. PubMed PMID: 10607884. 4: Standeven AM, Escobar M, Beard RL, Yuan YD, Chandraratna RA. Mitogenic effect of retinoid X receptor agonists in rat liver. Biochem Pharmacol. 1997 Aug 15;54(4):517-24. PubMed PMID: 9313779. 5: Thacher SM, Standeven AM, Athanikar J, Kopper S, Castilleja O, Escobar M, Beard RL, Chandraratna RA. Receptor specificity of retinoid-induced epidermal hyperplasia: effect of RXR-selective agonists and correlation with topical irritation. J Pharmacol Exp Ther. 1997 Aug;282(2):528-34. PubMed PMID: 9262312. 6: Standeven AM, Beard RL, Johnson AT, Boehm MF, Escobar M, Heyman RA, Chandraratna RA. Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic acid receptors. Fundam Appl Toxicol. 1996 Oct;33(2):264-71. PubMed PMID: 8921345.